The variations found between our group of patients with aortoiliac obstruction and another group with femoropopliteal obstruction suggest that disease in the two locations may differ in some ...

Primary Patency: SIRONA concluded that a primary patency of 73.8% was achieved by MagicTouch PTA against 75% of Paclitaxel ...

Concept Medical Inc., a global leader in innovative drug-delivery technology having its state-of-the-art manufacturing ...

SIRONA trial reveals that sirolimus-coated balloons by Concept Medical match the efficacy of paclitaxel-coated balloons for peripheral artery disease. Conducted in Germany and Austria, the RCT ...